UPDATE: Leidos (LDOS) Tops Q4 EPS by 17c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
Get Alerts LDOS Hot Sheet
Join SI Premium – FREE
Leidos (NYSE: LDOS) reported Q4 EPS of $1.51, $0.17 better than the analyst estimate of $1.34. Revenue for the quarter came in at $2.95 billion versus the consensus estimate of $2.84 billion.
Roger Krone, Leidos Chairman and Chief Executive Officer, commented: "We delivered strong fourth quarter results, including record organic revenue growth, increasing margins and significant year-over-year non-GAAP earnings growth. Our growth and execution momentum accelerated throughout 2019 and has continued into 2020 with significant new program wins and the opportunity to create value from our two recently announced acquisitions. I am confident that we are growing the company with the right talent, the right capabilities and the right strategy to continue to drive value for our customers, employees and shareholders."
GUIDANCE:
Leidos sees FY2020 EPS of $5.30-$5.65, versus the consensus of $5.52. Leidos sees FY2020 revenue of $12.6-13 billion, versus the consensus of $12.02 billion.
The Company\'s outlook for fiscal year 2020 is as follows:
- Revenues of $12.6 billion to $13.0 billion;
- Adjusted EBITDA margins of 10.0% to 10.2%;
- Non-GAAP diluted EPS of $5.30 to $5.65; and
- Cash flows provided by operating activities at or above $1.0 billion.
For earnings history and earnings-related data on Leidos (LDOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) tops earnings expectations but revenue falls short
- Innodata (INOD) Awarded New Programs from "Magnificent Seven" Big Tech Customer Valued at Approximately $20 Million in Annualized Run Rate Revenue
- Hilton hikes 2024 earnings outlook as Q1 results beat expectations, shares up
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!